Kilpatrick G J, Jenner P, Marsden C D
Eur J Pharmacol. 1984 Dec 15;107(1):71-8. doi: 10.1016/0014-2999(84)90093-1.
N-(chloroethyl)-norapomorphine (NCA) irreversibly inhibits striatal dopamine function, the binding of dopamine agonist ligands and dopamine-stimulated adenylate cyclase. A selective interaction of [3H]NCA with dopamine receptor sites would be of use in the characterisation and isolation of brain dopamine receptors. In this study the binding of [3H]NCA to homogenates of rat striatum was investigated. Binding of [3H]NCA to striatal preparations was saturable and irreversible and prevented with high affinity by dopamine agonist drugs with a catechol moiety. However, binding was not prevented in a stereoselective manner by the isomers of butaclamol, flupenthixol or sultopride. Nor was [3H]NCA binding specific to brain areas containing dopamine receptors. We conclude that [3H]NCA binding is not selective for dopamine receptors, although NCA inhibited both [3H]N,n-propylnorapomorphine (NPA) and [3H]spiperone binding in a non-competitive manner.
N-(氯乙基)-去甲阿扑吗啡(NCA)不可逆地抑制纹状体多巴胺功能、多巴胺激动剂配体的结合以及多巴胺刺激的腺苷酸环化酶。[3H]NCA与多巴胺受体位点的选择性相互作用将有助于脑多巴胺受体的表征和分离。在本研究中,对[3H]NCA与大鼠纹状体匀浆的结合进行了研究。[3H]NCA与纹状体制剂的结合是饱和且不可逆的,并且被具有儿茶酚部分的多巴胺激动剂药物以高亲和力阻断。然而,布他拉莫、氟哌噻吨或舒托必利的异构体并未以立体选择性方式阻断结合。[3H]NCA结合也并非对含有多巴胺受体的脑区具有特异性。我们得出结论,[3H]NCA结合对多巴胺受体没有选择性,尽管NCA以非竞争性方式抑制了[3H]N-正丙基去甲阿扑吗啡(NPA)和[3H]螺哌隆的结合。